Search

Author/Creator Stroebel, Benjamin M.

1. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. (1st January 2015)

Authors:
Fine, Jared M.; Renner, Daniel B.; Forsberg, Anna C.; Cameron, Rachel A.; Galick, Benjamin T.; Le, Clint; Conway, Patrick M.; Stroebel, Benjamin M.; Frey, William H.; Hanson, Leah R.
Journal:
Neuroscience letters
Issue:
Volume 584(2015)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. (1st January 2020)

Authors:
Fine, Jared M.; Stroebel, Benjamin M.; Faltesek, Katherine A.; Terai, Kaoru; Haase, Lucas; Knutzen, Kristin E.; Kosyakovsky, Jacob; Bowe, Tate J.; Fuller, Austin K.; Frey, William H.; Hanson, Leah R.
Journal:
Neuroscience letters
Issue:
Volume 714(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P2‐313: Intranasal deferoxamine prevents memory loss in the intracerebroventricular streptozotocin rat model of Alzheimer's disease. (1st July 2015)

Authors:
Fine, Jared M.; Forsberg, Anna C.; Stroebel, Benjamin M.; Verden, Dylan R.; Hamel, Katherine A.; Raney, Elise B.; Frey, William H.; Hanson, Leah R.
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7S:Part 13
Page Start:
P613
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗